Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress

Abstract The transcription factor NF-κB is critical for setting the cellular sensitivities to apoptotic stimuli, including DNA damaging anticancer agents. Central to NF-κB signaling pathways is NEMO/IKKγ, the regulatory subunit of the cytoplasmic IκB kinase (IKK) complex. While NF-κB activation by genotoxic stress provides an attractive paradigm for nuclear-to-cytoplasmic signaling pathways, the mechanism by which nuclear DNA damage modulates NEMO to activate cytoplasmic IKK remains unknown. Here, we show that genotoxic stress causes nuclear localization of IKK-unbound NEMO via site-specific SUMO-1 attachment. Surprisingly, this sumoylation step is ATM-independent, but nuclear localization allows subsequent ATM-dependent ubiquitylation of NEMO to ultimately activate IKK in the cytoplasm. Thus, genotoxic stress induces two independent signaling pathways, SUMO-1 modification and ATM activation, which work in concert to sequentially cause nuclear targeting and ubiquitylation of free NEMO to permit the NF-κB survival pathway. These SUMO and ubiquitin modification pathways may serve as anticancer drug targets.

[1]  C. Holmberg,et al.  Phosphorylation of Serine 303 Is a Prerequisite for the Stress-Inducible SUMO Modification of Heat Shock Factor 1 , 2003, Molecular and Cellular Biology.

[2]  A. Dejean,et al.  Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.

[3]  Seth J Davis,et al.  The Small Ubiquitin-like Modifier (SUMO) Protein Modification System in Arabidopsis , 2003, The Journal of Biological Chemistry.

[4]  S. Shumway,et al.  Novel IκBα Proteolytic Pathway in WEHI231 Immature B Cells , 1998, Molecular and Cellular Biology.

[5]  Shao-Cong Sun,et al.  Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: hijacking cellular IκB kinases , 1999, Oncogene.

[6]  Boris Pfander,et al.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.

[7]  J. Dixon,et al.  Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. , 2000, Science.

[8]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[9]  M. Karin,et al.  The Carboxyl-Terminal Region of IκB Kinase γ (IKKγ) Is Required for Full IKK Activation , 2002, Molecular and Cellular Biology.

[10]  J. Pober,et al.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.

[11]  G. Courtois,et al.  ATM Is Required for IκB Kinase (IKK) Activation in Response to DNA Double Strand Breaks* , 2000, The Journal of Biological Chemistry.

[12]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[13]  Brian D. Strahl,et al.  A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression , 2003, Nature.

[14]  L. Zon,et al.  SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. , 2002, Molecular cell.

[15]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[16]  S. Elledge,et al.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. , 2000, Genes & development.

[17]  C. Pickart,et al.  Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.

[18]  Nanxin Li,et al.  Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[20]  S. Miyamoto,et al.  Postrepression Activation of NF-κB Requires the Amino-Terminal Nuclear Export Signal Specific to IκBα , 2001, Molecular and Cellular Biology.

[21]  E. Elion,et al.  Nuclear Shuttling of Yeast Scaffold Ste5 Is Required for Its Recruitment to the Plasma Membrane and Activation of the Mating MAPK Cascade , 1999, Cell.

[22]  Chi A. Ma,et al.  Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia , 2001, Nature Immunology.

[23]  H. Nakano,et al.  The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. , 2003, Genes & development.

[24]  M. Karin,et al.  The mammalian ultraviolet response is triggered by activation of src tyrosine kinases , 1992, Cell.

[25]  A. Fischer,et al.  X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling , 2001, Nature Genetics.

[26]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[27]  S. Miyamoto,et al.  The Zinc Finger Domain of NEMO Is Selectively Required for NF-κB Activation by UV Radiation and Topoisomerase Inhibitors , 2002, Molecular and Cellular Biology.

[28]  R. Hay,et al.  SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting* , 2001, The Journal of Biological Chemistry.

[29]  Sheng-Cai Lin,et al.  SUMO-1 Modification of the C-terminal KVEKVD of Axin Is Required for JNK Activation but Has No Effect on Wnt Signaling* , 2002, The Journal of Biological Chemistry.

[30]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[31]  A. Israël,et al.  Induction of the NF-κB Cascade by Recruitment of the Scaffold Molecule NEMO to the T Cell Receptor , 2003 .

[32]  John Calvin Reed,et al.  Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. , 2000, Science.

[33]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[34]  T. Hunter,et al.  Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus , 1995, Current Biology.

[35]  L. Liu,et al.  SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Hay,et al.  SUMO‐1 modification activates the transcriptional response of p53 , 1999, The EMBO journal.

[37]  S. Shumway,et al.  NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. , 2000, The Journal of biological chemistry.

[38]  A. Dejean,et al.  Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.

[39]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[40]  R. Gaynor,et al.  Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.

[41]  R. Hay,et al.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.

[42]  A. Caudy,et al.  Regulation of Transcriptional Activation Domain Function by Ubiquitin , 2001, Science.

[43]  F. Melchior,et al.  A Small Ubiquitin-Related Polypeptide Involved in Targeting RanGAP1 to Nuclear Pore Complex Protein RanBP2 , 1997, Cell.

[44]  R. Abraham.  Cell cycle checkpoint signaling through the ATM and ATR kinases. , 2001, Genes & development.

[45]  René Bernards,et al.  Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.

[46]  W. Tam,et al.  IkappaB family members function by different mechanisms. , 2001, The Journal of biological chemistry.

[47]  S. Jentsch,et al.  Ubiquitin and proteasomes: Sumo, ubiquitin's mysterious cousin , 2001, Nature Reviews Molecular Cell Biology.

[48]  Minoru Yoshida,et al.  A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes , 2000 .

[49]  W. Tam,et al.  IκB Family Members Function by Different Mechanisms* , 2001, The Journal of Biological Chemistry.

[50]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[51]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[52]  G. Ghosh,et al.  IκBβ, but Not IκBα, Functions as a Classical Cytoplasmic Inhibitor of NF-κB Dimers by Masking Both NF-κB Nuclear Localization Sequences in Resting Cells* , 2001, The Journal of Biological Chemistry.

[53]  S. Klauck,et al.  Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti , 2000, Nature.

[54]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[55]  G. Blobel,et al.  A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex , 1996, The Journal of cell biology.

[56]  G. Luo,et al.  Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation , 2003, Oncogene.

[57]  M. Kastan,et al.  The many substrates and functions of ATM , 2000, Nature Reviews Molecular Cell Biology.